Conditional-approval schemes, which postpone a new health technology’s ultimate pricing and reimbursement decisions until after the collection of post-market-approval data, can mitigate uncertainty regarding the technology’s health-economic value. Analytical work that evaluates these schemes...

Type 2 Diabetes Mellitus (T2DM), the epidemic of the 21st century, accounts for 4.6 million deaths globally and for 11% of the global health expenditure. Several different public health, primary preventive, and secondary interventions promise better health outcomes and cost savings. This paper...

Intensive care units are important departments in hospitals that are complicated in that they have both urgent and elective patients with a variety of specialty needs. Their design involves important operations strategy decisions, such as whether there are several specialized units for certain...

We consider contracting issues in the care of patients with chronic conditions within the principal-agent framework. The government, acting as a principal, contracts with several health care providers in an effort to maximise population health minus the cost. We consider the decision of whether...